Strohl Medical Technologies, founded in 2009 and based in Norwell, Massachusetts, is dedicated to simplifying neurophysiological assessments through innovative technology. The company's core mission is to provide quick and accurate evaluations of a patient's neurophysiological condition using evoked potential technology. Strohl Medical Technologies offers a portable stroke detection device that monitors brain activity and hearing, with electrodes placed on the wrists and knees, aiming to revolutionize the way strokes are detected and managed.

Key figures associated with Strohl Medical Technologies include its founders and early investors who have contributed to its development and growth. The company has achieved significant milestones in medical technology by creating a user-friendly, portable device that enhances stroke detection accuracy and speed. Strohl Medical Technologies' impact lies in its potential to improve patient outcomes through timely and precise neurophysiological assessments, positioning itself as a crucial player in the medical device industry.